Zimmer Biomet (Biomet) is a medical device manufacturer founded in 1977, and headquartered in Warsaw, Indiana. Its official name was simply “Biomet” until “Zimmer” purchased it in 2015. Biomet M2a hip implants are hurting patients in the US and United Kingdom (UK).
The Magnum M2a Hip Implant Has a High Revision Rate
The M2a Magnum is a metal-on-metal brand of cup and head. This means that both the cup and head implants are made of cobalt-chromium. Studies show that between 6% and 7% of patients who receive the M2a Magnum need revision surgery within 5 years. Those patients needed revision surgery because their implants were poisoning their blood with high metal levels. High metal levels in the blood can cause a host of problems including:
- Bone death (osteolysis)
- Tissue death (necrosis)
One somewhat unique side effect patients experience from the M2a Magnum is clicking. In some cases, as the M2a Magnum wears out it can cause an audible clicking noise. Unfortunately, all of these problems eventually necessitate revision surgery.
Biomet Paid Out Big in the US
On April 15, 2014, Biomet signed a settlement agreement with hundreds of implant patients. Patients are eligible to receive a base award of $200,000 if they meet the following conditions:
- Had a Biomet M2a Magnum hip implant
- Filed a lawsuit against Biomet on or before April 15, 2014
- Had the Biomet M2a Magnum hip implant removed more than 180 days after it was implanted
If you meet those conditions, then you may be entitled to at least $200,000.
Biomet Tried to Cover Its Tracks in the United Kingdom
Biomet hasn’t recalled M2a Magnums in the US, but it has recalled a close cousin of the M2a Magnum – the M2a 38 mm – in the UK. On April 12, 2016, Biomet issued an Urgent Field Safety Notice (FSC) regarding M2a Magnums in England and Wales. An FSC is an official communication in the UK which has two purposes:
- Warning—tells doctors that something is wrong with the company’s product
- Recommendation—tells doctors what to do with patients who were or are exposed to that product
Here is a breakdown of Biomet’s FSC.
- Warning—patients with M2a 38 mms need revision surgery far more often than they should because they are getting high metal levels in their blood.
- Recommendation—doctors should test patients with M2a 38 mms, and if the test results are abnormal, then the doctors should remove the M2a 38 mms and replace them with different, safer implants.
Biomet M2a Hip Implants Are Dangerous
Here in the US, Biomet is paying out millions of dollars over the M2a Magnum. In the UK, Biomet issued an urgent warning over a similar device. Clearly something is wrong with these dangerous products.